← Back to all trials
Not Yet Recruiting
NCT07839884
A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time
Conditions: Moderate to Severe Chronic Obstructive Pulmonary Disease
Sex: All
Ages: 35 Years – 80 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 1360
Sponsor: Pfizer
Summary
A Continuation Study of Tilrekimig in Adults with Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About this Medicine when Used for a Long Period of Time.
Eligibility Criteria
INCLUSION CRITERIA
* Participants who completed parent study C4531031.
* Individuals of childbearing potential must be willing to use a highly effective method of contraception.
EXCLUSION CRITERIA
* Ongoing safety-significant AE.
* Parent-study SAE incompatible with continued participation.
* Medical, laboratory, psychiatric, or behavioral condition that increases risk or interferes with study participation.
* Pregnancy or breastfeeding.
Source: ClinicalTrials.gov (NCT07839884). StuddyBuddy aggregates publicly available trial information.